10.26 USD
▲-0.09+1.68%
盘后 10.09 0.00%
2026-08-03
市值
$536.35M
市盈率
—
EPS
-2.64
股息率
—
52 周区间
5.11 – 14.00
成交量
478.30K
Beta
2.70
目标价
28.22
52W 低 5.1152W 高 14.00
价格走势
公司简介
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company’s lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is...